23-24 April, Prague, Czech Republic
3rd Cardiovascular Clinical Trials Outsoucing Congress
The ongoing globalisation of clinical trials is having an ever increasing impact on the bio-pharmaceutical industry. Driven by the need to reduce development costs and the need to access larger numbers of patients so called emerging regions such as Latin America, Central and Eastern Europe, Russia, Middle East, India and Asia Pacific are now playing an important role.
The 3rd Cardiovascular Clinical Trials in Emerging Countries will examine issues such as regulatory and organisational challenges, appropriate trial design, data collection, patient enrolment and multi national cost saving strategies.
This conference will be co-located with the 4th Oncology Clinical Trials in Emerging Regions. 92 senior level delegates attended this event last year when it was also co-located with the 2nd Oncology Clinical Trials in emerging Countries. Some of the vendor companies who attended were Arianne Corporation, DHL Supply Chain, Averion International, ClinStar, Quest Diagnostics, ClinTec International, CoreLab Partners, ERT, Quintiles, Interlab, Latin America Trial Network, Medidata Solutions, Orion Clinical Research, Synergy Research, Synevo Central Lab, Worldwide Clinical Trials.
Click here for more information on Cardiovascular Clinical Trials in Emerging Countries.
“The best conference this year. Sharing a picture of the implementation of CT in all these regions”
Project Manager, Boehringer Ingelheim